SPARTA, NCT01983241 / 2013-001870-38: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) |
|
|
| Active, not recruiting | 3 | 341 | Europe, Canada, US, RoW | Alpha-1 MP, Prolastin-C, 0.9% Sodium Chloride for Injection, USP, Saline | Grifols Therapeutics LLC | Pulmonary Emphysema in Alpha-1 PI Deficiency | 07/26 | 07/26 | | |
NCT03870828: Clinical Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study |
|
|
| Not yet recruiting | N/A | 210 | Europe | Bronchoalveolar lavage and taking bronchial mucosa samples, 6minute walk test, 6MWT, Arterial blood gas, ABG, Blood drawing | Medical University of Silesia | Interstitial Lung Disease, Interstitial Pneumonia, Interstitial Fibrosis, Autoimmune Diseases | 02/20 | 12/25 | | |
